Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infections, Papillomavirus”

913 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 913 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05797246
What this trial is testing

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Who this might be right for
Respiratory Tract DiseasesNeoplasmsNeoplasms by Histologic Type+12 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)UnknownNCT02593968
What this trial is testing

Yallaferon in Chinese Population

Who this might be right for
HPV Infection
Lee's Pharmaceutical Limited 100
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Not applicableStudy completedNCT04401670
What this trial is testing

Cervical Cancer Screening in Cameroon

Who this might be right for
Cervical CancerHIV/AIDS
Albert Einstein College of Medicine 873
Not applicableStudy completedNCT04587050
What this trial is testing

Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV

Who this might be right for
HIV InfectionsHuman Papillomavirus InfectionCervical Cancer
Imperial College London 57
Large-scale testing (Phase 3)WithdrawnNCT00733122
What this trial is testing

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC
Not applicableUnknownNCT00892866
What this trial is testing

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Who this might be right for
Atypical Endometrial HyperplasiaHuman Papillomavirus InfectionStage 0 Cervical Cancer AJCC v7
GOG Foundation 877
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Testing effectiveness (Phase 2)Study completedNCT00359619
What this trial is testing

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 383
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06210854
What this trial is testing

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

Who this might be right for
HPV Infection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Not applicableStudy completedNCT01077856
What this trial is testing

GARDASIL™ Vaccine Impact in Population Study (V501-033)

Who this might be right for
Human Papillomavirus Infections
Merck Sharp & Dohme LLC 54,516
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Not applicableUnknownNCT01897129
What this trial is testing

Human Papillomavirus and Pregnancy

Who this might be right for
HPV-infection in Pregnant Women
Ulla Bonde van Zwol 546
Not applicableUnknownNCT06245486
What this trial is testing

Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses

Who this might be right for
Human Papillomavirus Infection
Liaquat University of Medical & Health Sciences 150
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Not applicableActive Not RecruitingNCT05669911
What this trial is testing

Development of a Self-collection Device for Cervical Cancer Screening

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Human Papilloma Virus
Teal Health, Inc. 235
Not applicableLooking for participantsNCT05284877
What this trial is testing

The Organ Transplant Recipient HPV and Skin Cancer Study

Who this might be right for
Solid Organ Transplant RecipientSkin CancerSkin Dysplasia+4 more
Merete Haedersdal 1,500
Testing effectiveness (Phase 2)Study completedNCT00316693
What this trial is testing

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,046
Post-approval studies (Phase 4)Looking for participantsNCT05495906
What this trial is testing

Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Who this might be right for
HPVHuman Papilloma VirusHuman Immunodeficiency Virus
University of British Columbia 275
Load More Results